A REVIEW OF MOUNJARO TIRZEPATIDE FOR WEIGHT LOSS

MOUNJARO has not been examined in patients with non-proliferative diabetic retinopathy requiring acute therapy, proliferative diabetic retinopathy, or diabetic macular edema. Sufferers having a background of diabetic retinopathy must be monitored for development of diabetic retinopathy.Portion of the extraordinary weight loss final results found in